Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NativeMed vs Science & Co

By GLP-1 ScorecardUpdated

NativeMedFactor scores not reassessed.
Site position #289

Lower score

Science & CoFactor scores not reassessed.
Site position #82

Higher score

Score comparison

Science & Co has the higher recorded score — 72.9/100 to 62.7/100.

Science & Co grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. States in its own footer that it is not a compounding facility, and explains its own asterisk in its own FAQ — two things almost nothing else here does.

Before you choose

Before comparing the headline prices, the NativeMed review and the Science & Co review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, NativeMed vs Trellis Vitality and NP2GO vs Science & Co compare each of them with another graded program, and the list of alternatives to NativeMed ranks the programs closest to NativeMed on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueEven
74
74
Dose & formulationScience & Co +10
64
74
Clinical oversightScience & Co +21
55
76
Labs & monitoringScience & Co +2
53
55
FulfillmentScience & Co +13
67
80
Contract termsScience & Co +27
55
82
NativeMed · top barScience & Co · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricNativeMedScience & Co
WeighScore62.7/10072.9/100
GradeCC
Site position#289#82
Semaglutide$149/mo (promotional rate, compounded)$149/mo month-to-month ($79 only on a 12-month plan)
Tirzepatide$183/mo (promotional rate, compounded)$199/mo month-to-month ($125 only on a 12-month plan)
CoverageCoverage not publishedNot publicly listed
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
NativeMed

Site position #289 · C

Factor scores not reassessed.

FDAWarning letter issued to NativeMed LLC dba NativeMed in June 2026. See the FDA warning-letter database.

Strengths

  • LegitScript Certified (verifiable in the footer)
  • Promotional pricing shown publicly: $149/mo semaglutide, $183/mo tirzepatide
  • Online questionnaire intake, with a live visit added when state law requires it

What to consider

  • Pharmacy partners aren't named — described only as 'USA-based' or 'accredited' pharmacies
  • States served aren't listed publicly
  • Prices are promotional — confirm whether they hold past month one or rise to the $299/$399 regular rate
  • FDA issued NativeMed LLC dba NativeMed a warning letter in June 2026; the letter is public in FDA's warning-letter database
Science & Co

Site position #82 · C

Factor scores not reassessed.

Strengths

  • States twice in its footer that "Science and Co, Inc. is not a 503A or 503B compounding facility"
  • Its own FAQ names the commitment behind the headline: "Plans start at $125 a month on the 12 month plan"
  • The printed saving corroborates the reference price — 125 divided by 199 is 63%, exactly the "Save 37%" shown
  • "Same Price, Any Dose", with no hidden fees, no monthly membership and free shipping stated in the FAQ
  • Names its operating entity and state of incorporation, and says every batch is third-party tested

What to consider

  • The number it leads with is a twelve-month commitment; the per-month rates are $149 and $199
  • Only two figures are published per drug, so a three- or six-month plan cannot be priced without starting an intake
  • It says it is not a compounding facility but never names the pharmacy that is
  • No lab or monitoring protocol is published
  • Injection only on the pages read — no oral route and no brand lane

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard